Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 9,205-9,216 of 10,592
Drug study icon
Active Not RecruitingNCT06869187

ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolarity in Adults

This study is looking at whether ABX-002 can help people with bipolarity Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Autobahn Therapeutics, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00553319

Adderall-XR for Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence

This study exists to compare options and see whether the medication Adderall-XR offers something meaningfully different. Researchers are trying to understand whether the medication Adderall-XR can improve attention, thinking, or day-to-day functioning.

In United States
ADHDDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
ADHD
Drug study icon
CompletedNCT00221962

Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)

This study exists to understand whether the medication Aripiprazole is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication Aripiprazole can improve attention, thinking, or day-to-day functioning.

In United States
ADHDDrugFrom 8 Years to 12 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
ADHD
Drug study icon
CompletedNCT00194077

Aripiprazole (Abilify) in Children With Symptoms of Mania

This study exists to understand whether the medication Aripiprazole is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication Aripiprazole can improve attention, thinking, or day-to-day functioning.

In United States
BipolarityDrugFrom 4 Years to 9 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Bipolarity
Drug study icon
CompletedNCT00194012

Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolarity

This study exists to understand whether the medication Aripiprazole is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication Aripiprazole in practice and what may need to be adjusted.

In United States
BipolarityDrugFrom 5 Years to 17 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Bipolarity
Drug study icon
CompletedNCT00036348

Aripiprazole in people with a History of Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States
BipolarityDrugOver 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.